Hellen Berger is a business writer based in Sao Paulo, Brazil.
The Brazilian economy is being impacted by internal and external factors, and forecast figures are being quickly revised downwards. Hellen Berger reports.
Brazil is the first Latin American country to emerge as a global biopharmaceutical collaborator. Hellen Berger reports.
New regulation offers drug options for patients with rare, severe, or debilitating illnesses.
Brazil's deal to produce a generic version of a BMS AIDS drug has met with resistance — but the health ministry remains defiant. Hellen Berger reports.
How Digital Medicine Can Pinpoint Dosing Regimens to Optimize Drug Efficacy and Safety
Sponsored By Oracle
Multi-faceted Approaches to Meet Payer and Regulatory Evidence Requirements
Sponsored By UBC Express Scripts
Overcoming the Life Sciences Content Conundrum in a Multichannel World
Sponsored By Veeva